No Picture
News

Wellcome looks for backers of an $8B-plus Covid-19 fund; ReNeuron signs on another pharma partner

→ The nonprofit Wellcome is looking to raise $8 billion to fund the development of new drugs and vaccines that can fight Covid-19. The UK organization says that represents just a fraction of the money that’s been set aside to safeguard economies and wo… […]

No Picture
News

Pluto7 has been Awarded the 2019 Google Cloud Specialization Partner of the Year Award for Data and Analytics

SAN FRANCISCO–(BUSINESS WIRE)– #ai–Pluto7, a Google Cloud Premier Partner in North America and India received the 2019 Google Cloud Specialization Partner of the Year Award for Data and Analytics. Pluto7 has been awarded this prestigious honor for i… […]

No Picture
News

Mendel Launches AI-powered Search Engine to Analyze More Than 50,000 Coronavirus Papers

SAN JOSE, Calif.–(BUSINESS WIRE)–Mendel, the leader in clinical AI technologies, announced the launch of a new search engine using proprietary AI to absorb more than 50,000 coronavirus research papers and answer questions related to COVID-19. DCM, a … […]

No Picture
News

Covid-19 roundup: Trump asks biotech execs to send drugs to Boris Johnson; Martin Shkreli wants Covid get-out-of-jail-free pass

A month after he first gathered Big Pharma and big biotech executives around a table at the White House, President Trump held a conference call yesterday with executives from four different drugmakers pursuing treatments for Covid-19: Regeneron, Genent… […]

No Picture
News

Gilead gets in on the microbiome game with a $38M pact, up to $1.5B in milestones

In what had been shaping up to be a major year for microbiome biotechs, Gilead is getting in on the action.
America’s newly most watched big biotech announced a four-year, $38 million upfront pact with Second Genome to identify biomarkers that can meas… […]

No Picture
News

Another protein degradation biotech emerges, with the promise of a new approach from an old hand

The money keeps pouring in for protein degradation.
A field that six years ago had the financial equivalent of tumbleweed is now flush with cash. Last month, a pair of  biotechs, now backed with big pharma and big biotech deals, landed a total of $222 … […]